All In MedTech

FDA Clearance Tracker · P140002-S032

MISAGO(TM) RX Self-expanding Peripheral Stent

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jul 16, 2026 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jul 16, 2026

Approved

Time to decision

199 days

Received Dec 29, 2025. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Panel Track

Device class

Class III

The decision

FDA number
P140002-S032
Device name
MISAGO(TM) RX Self-expanding Peripheral Stent
Applicant location
Hatagaya
Received
Dec 29, 2025
Decided
Jul 16, 2026
Decision
Approved
Supplement type
Panel Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P140002

Device type

Device class
Class III

Every decision under product code NIO

FDA's approval statement

As written in FDA's record.

The Misago RX Self-expanding Peripheral Stent is indicated to improve the luminal diameter in patient with de novo, restenotic and/or occlusive atherosclerotic lesion(s) in the common and/or external iliac artery. The reference vessel diameters range from 4.0 mm to 9.0 mm and the lesion length is up to 120 mm.

Source documents

Other decisions for Terumo Medical Corporation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.